These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 26868689)

  • 1. Incidence, Timing, and Predictors of Valve Hemodynamic Deterioration After Transcatheter Aortic Valve Replacement: Multicenter Registry.
    Del Trigo M; Muñoz-Garcia AJ; Wijeysundera HC; Nombela-Franco L; Cheema AN; Gutierrez E; Serra V; Kefer J; Amat-Santos IJ; Benitez LM; Mewa J; Jiménez-Quevedo P; Alnasser S; Garcia Del Blanco B; Dager A; Abdul-Jawad Altisent O; Puri R; Campelo-Parada F; Dahou A; Paradis JM; Dumont E; Pibarot P; Rodés-Cabau J
    J Am Coll Cardiol; 2016 Feb; 67(6):644-655. PubMed ID: 26868689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of anticoagulation therapy on valve haemodynamic deterioration following transcatheter aortic valve replacement.
    Del Trigo M; Muñoz-García AJ; Latib A; Auffret V; Wijeysundera HC; Nombela-Franco L; Gutierrez E; Cheema AN; Serra V; Amat-Santos IJ; Kefer J; Benitez LM; Leclercq F; Mangieri A; Le Breton H; Jiménez-Quevedo P; Garcia Del Blanco B; Dager A; Abdul-Jawad Altisent O; Puri R; Pibarot P; Rodés-Cabau J
    Heart; 2018 May; 104(10):814-820. PubMed ID: 29440192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry.
    Vemulapalli S; Holmes DR; Dai D; Matsouaka R; Mack MJ; Grover FL; Makkar RR; Thourani VH; Douglas PS
    Am Heart J; 2018 Jan; 195():1-13. PubMed ID: 29224637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, Predictors, and Clinical Impact of Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement in Asian Patients: The OCEAN-TAVI Registry.
    Miyasaka M; Tada N; Taguri M; Kato S; Enta Y; Otomo T; Hata M; Watanabe Y; Naganuma T; Araki M; Yamanaka F; Shirai S; Ueno H; Mizutani K; Tabata M; Higashimori A; Takagi K; Yamamoto M; Hayashida K;
    JACC Cardiovasc Interv; 2018 Apr; 11(8):771-780. PubMed ID: 29673509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could anticoagulation avoid bioprosthesis subclinical thrombosis in patients undergoing transcatheter aortic valve replacement?
    Huchet F; Letocart V; Guerin P; Cueff C; Roy-Giocosa J; Guyomarch-Delasalle B; Jaafar P; Manigold T
    Arch Cardiovasc Dis; 2018 Jan; 111(1):25-32. PubMed ID: 28943264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve Replacement: Incidence, Characteristics, and Treatment Outcomes.
    Jose J; Sulimov DS; El-Mawardy M; Sato T; Allali A; Holy EW; Becker B; Landt M; Kebernik J; Schwarz B; Richardt G; Abdel-Wahab M
    JACC Cardiovasc Interv; 2017 Apr; 10(7):686-697. PubMed ID: 28385406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
    Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Bioprosthetic Aortic Valve Degeneration.
    Nitsche C; Kammerlander AA; Knechtelsdorfer K; Kraiger JA; Goliasch G; Dona C; Schachner L; Öztürk B; Binder C; Duca F; Aschauer S; Zimpfer D; Bonderman D; Hengstenberg C; Mascherbauer J
    JACC Cardiovasc Imaging; 2020 Feb; 13(2 Pt 1):345-353. PubMed ID: 30878425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic durability of transcatheter aortic valves using the updated Valve Academic Research Consortium-2 criteria.
    Kumar A; Sato K; Banerjee K; Narayanswami J; Betancor J; Menon V; Mohananey D; Anumandla AK; Sawant AC; Krishnaswamy A; Tuzcu EM; Jaber W; Mick S; Svensson LG; Popović ZB; Blackstone EH; Kapadia SR
    Catheter Cardiovasc Interv; 2019 Mar; 93(4):729-738. PubMed ID: 30312995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Durability of Transcatheter Aortic Valve Prostheses.
    Blackman DJ; Saraf S; MacCarthy PA; Myat A; Anderson SG; Malkin CJ; Cunnington MS; Somers K; Brennan P; Manoharan G; Parker J; Aldalati O; Brecker SJ; Dowling C; Hoole SP; Dorman S; Mullen M; Kennon S; Jerrum M; Chandrala P; Roberts DH; Tay J; Doshi SN; Ludman PF; Fairbairn TA; Crowe J; Levy RD; Banning AP; Ruparelia N; Spence MS; Hildick-Smith D
    J Am Coll Cardiol; 2019 Feb; 73(5):537-545. PubMed ID: 30732706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early hemodynamics and clinical outcomes of isolated aortic valve replacement with stentless or transcatheter valve in intermediate-risk patients.
    Repossini A; Di Bacco L; Passaretti B; Grubitzsch H; Schäfer C; Claus B; Giroletti L; Folliguet T; Bisleri G; Fischlein T; Santarpino G; Di Bartolomeo R; Laborde F; Muneretto C
    J Thorac Cardiovasc Surg; 2017 Mar; 153(3):549-558.e3. PubMed ID: 27939031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The TOPAS-TAVI Registry.
    Ribeiro HB; Lerakis S; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto WY; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Puri R; Pelletier-Beaumont E; Côté M; Pibarot P; Rodés-Cabau J
    J Am Coll Cardiol; 2018 Mar; 71(12):1297-1308. PubMed ID: 29566812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Transcatheter Aortic Valve Function With and Without Therapeutic Anticoagulation.
    Hiremath PG; Kearney K; Smith B; Don C; Dvir D; Aldea G; Reisman M; McCabe JM
    J Invasive Cardiol; 2017 Nov; 29(11):391-396. PubMed ID: 29086729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioprosthetic valve fracture: Technical insights from a multicenter study.
    Allen KB; Chhatriwalla AK; Saxon JT; Cohen DJ; Nguyen TC; Webb J; Loyalka P; Bavry AA; Rovin JD; Whisenant B; Dvir D; Kennedy KF; Thourani V; Lee R;
    J Thorac Cardiovasc Surg; 2019 Nov; 158(5):1317-1328.e1. PubMed ID: 30857820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement.
    Gleason TG; Schindler JT; Adams DH; Reardon MJ; Kleiman NS; Caplan LR; Conte JV; Deeb GM; Hughes GC; Chenoweth S; Popma JJ
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):85-96. PubMed ID: 27085389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.
    Chakravarty T; Søndergaard L; Friedman J; De Backer O; Berman D; Kofoed KF; Jilaihawi H; Shiota T; Abramowitz Y; Jørgensen TH; Rami T; Israr S; Fontana G; de Knegt M; Fuchs A; Lyden P; Trento A; Bhatt DL; Leon MB; Makkar RR; ;
    Lancet; 2017 Jun; 389(10087):2383-2392. PubMed ID: 28330690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Discharge Location After Transcatheter Aortic Valve Replacement on 1-Year Outcomes in Women: Results From the WIN-TAVI Registry.
    Mehilli J; Chandrasekhar J; Sartori S; Chieffo A; Petronio AS; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Jochheim D; Zadrozny M; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Moalem K; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    Can J Cardiol; 2019 Feb; 35(2):199-207. PubMed ID: 30760427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and impact of myocardial injury after transcatheter aortic valve replacement: a multicenter registry.
    Ribeiro HB; Nombela-Franco L; Muñoz-García AJ; Lemos PA; Amat-Santos I; Serra V; de Brito FS; Abizaid A; Sarmento-Leite R; Puri R; Cheema AN; Ruel M; Nietlispach F; Maisano F; Moris C; Del Valle R; Urena M; Abdul Jawad Altisent O; Del Trigo M; Campelo-Parada F; Jimenez Quevedo P; Alonso-Briales JH; Gutiérrez H; García Del Blanco B; Perin MA; Siqueira D; Bernardi G; Dumont É; Côté M; Pibarot P; Rodés-Cabau J
    J Am Coll Cardiol; 2015 Nov; 66(19):2075-2088. PubMed ID: 26541917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.